| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS20030199 | HPV | ENSG00000105679.9 | protein_coding | GAPDHS | No | No | 26330 | O14556 |
| TVIS20030512 | HPV | ENSG00000105679.9 | protein_coding | GAPDHS | No | No | 26330 | O14556 |
| TVIS20029380 | HPV | ENSG00000105679.9 | protein_coding | GAPDHS | No | No | 26330 | O14556 |
| TVIS20030200 | HPV | ENSG00000105679.9 | protein_coding | GAPDHS | No | No | 26330 | O14556 |
| TVIS20029381 | HPV | ENSG00000105679.9 | protein_coding | GAPDHS | No | No | 26330 | O14556 |
| TVIS20030201 | HPV | ENSG00000105679.9 | protein_coding | GAPDHS | No | No | 26330 | O14556 |
| TVIS20029382 | HPV | ENSG00000105679.9 | protein_coding | GAPDHS | No | No | 26330 | O14556 |
| TVIS20030202 | HPV | ENSG00000105679.9 | protein_coding | GAPDHS | No | No | 26330 | O14556 |
| TVIS20029383 | HPV | ENSG00000105679.9 | protein_coding | GAPDHS | No | No | 26330 | O14556 |
| TVIS20030203 | HPV | ENSG00000105679.9 | protein_coding | GAPDHS | No | No | 26330 | O14556 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | GAPDHS |
|---|---|
| DrugBank ID | DB01593 |
| Drug Name | Zinc |
| Target ID | BE0000720 |
| UniProt ID | O14556 |
| Regulation Type | |
| PubMed IDs | 14534351 |
| Citations | She YM, Narindrasorasak S, Yang S, Spitale N, Roberts EA, Sarkar B: Identification of metal-binding proteins in human hepatoma lines by immobilized metal affinity chromatography and mass spectrometry. Mol Cell Proteomics. 2003 Dec;2(12):1306-18. Epub 2003 Oct 7. |
| Groups | Approved; Investigational |
| Direct Classification | Homogeneous transition metal compounds |
| SMILES | [Zn] |
| Pathways | Dihydropyrimidinase Deficiency; Rofecoxib Action Pathway; Losartan Action Pathway; AICA-Ribosiduria; Canavan Disease; Quinapril Action Pathway; Alkaptonuria; Eprosartan Action Pathway; gamma-Glutamyltransferase Deficiency; Pterine Biosynthesis; Sulindac Action Pathway; Rescinnamine Action Pathway; Piroxicam Action Pathway; Nabumetone Action Pathway; 2-Hydroxyglutric Aciduria (D and L Form); beta-Ureidopropionase Deficiency; Vitamin B6 Metabolism; Retinol Metabolism; Valsartan Action Pathway; Valdecoxib Action Pathway; Irbesartan Action Pathway; Adenosine Deaminase Deficiency; Hawkinsinuria; Methionine Metabolism; Ramipril Action Pathway; Benazepril Action Pathway; beta-Alanine Metabolism; Aspartate Metabolism; Diclofenac Action Pathway; Galactosemia |
| PharmGKB | PA451956 |
| ChEMBL | CHEMBL1201279 |
